Cite
HARVARD Citation
McGuigan, C. et al. (2016). Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. Journal of neurology, neurosurgery and psychiatry. 87 (2), pp. 117-125. [Online].